WILMINGTON, MA — Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced [yesterday] that its QS-B220 desktop explosives trace detector has been selected in a Romanian airport tender. With this sale, Implant Sciences’ trace detectors have been sold to customers in 70 different countries around the world, amounting to a total of approximately 4,400 units.
“Implant Sciences has, in this year, doubled the number of units sold in its entire history of selling trace detectors,” stated Dr. Darryl Jones, Implant Sciences’ Vice President of Global Sales and Marketing. “This sale to Romania is another example of smaller EU country airports following market trends set by other, larger airports. We continue to capitalize on our tremendous sales momentum globally.”
“Over the last several months, our QS-B220 has been recognized by some of the most high-profile airport security operators and ETD customers in the world, being selected in tenders across ten different EU countries,” added Dr. Bill McGann, CEO of Implant Sciences. “We believe this is a clear sign that our recent momentum is being sustained, as these highly sophisticated customers look to Implant Sciences as the emerging leader in trace detection and to our technology as being the new standard in the market.”
About the QS-B220 Desktop Explosives Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company’s team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across 70 countries worldwide. The Company’s ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., ECAC in Europe, CAAC and the Ministry of Public Safety in China, Russia FSB, STAC in France, and the German Ministry of the Interior. It has also received the 2015 GSN Airport/Seaport/Border Security Award for “Best Security Checkpoint”. All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on the Company and its products, please visit the Company’s website at http://www.implantsciences.com.
(NOTE: The above press release is from Implant Sciences Corporation.)
Like Wilmington Apple on Facebook! Follow Wilmington Apple on Twitter! Subscribe to Wilmington Apple’s daily email newsletter HERE! Got a comment, question, photo, press release, or news tip? Email wilmingtonapple@gmail.com!
Wilmington Apple 